Global In Vitro Diagnostics Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
to be the emerging segment in the global IVD market. Key players in the<br />
in vitro diagnostics market are working on introducing epigenomicsbased<br />
diagnostic products to stay ahead in the competition.<br />
Browse Full Research Report on <strong>In</strong> <strong>Vitro</strong> <strong>Diagnostics</strong> <strong>Market</strong>:<br />
http://www.transparencymarketresearch.com/in-vitro-diagnostictests.html<br />
The global in vitro diagnostics market has been segmented on the basis<br />
of products and geography. <strong>In</strong> terms of geography, this market can be<br />
divided into Asia Pacific, Europe, North America, and Rest of the World.<br />
The products in the global in vitro diagnostics market are clinical<br />
chemistry IVDs, immunoassay IVDs, blood testing IVDs, molecular<br />
diagnostics, diabetes testing IVDs, and other IVDs.<br />
The increasing demand for IVDs from regions such as Asia Pacific and<br />
Latin America is rapidly changing the landscape of the in vitro<br />
diagnostics market across the globe. Back in 2011, Europe and North<br />
America held a large share in the in vitro diagnostics market due to the<br />
presence of organized clinical research facilities and growing healthcare<br />
awareness. However, the tables have turned, as developing economies<br />
are now in the limelight and are attracting important market players with<br />
their pool of unmet opportunities.<br />
The main drivers for the in vitro diagnostics market in Europe are the<br />
growing incidence of illnesses such as tuberculosis, sexually transmitted<br />
infections, and pneumonia, cardiovascular diseases (CVDs), diabetes<br />
mellitus, and cancer, and growing interest in quick diagnostics and<br />
point-of-care testing.
Change language